Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genomic instability in the naturally and prematurely aged myocardium [RNA-Seq]

ABSTRACT: Genomic instability in the naturally and prematurely aged myocardium [RNA-Seq]

PROVIDER: PRJNA510746 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8352390_1.fastq.gz	Fastqsanger.gz
	SRR8352390_2.fastq.gz	Fastqsanger.gz
	SRR8352400_1.fastq.gz	Fastqsanger.gz
	SRR8352400_2.fastq.gz	Fastqsanger.gz
	SRR8352410_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 56

Similar Datasets

Genomic instability in the naturally and prematurely aged myocardium

Project description:Genomic instability in the naturally and prematurely aged myocardium

| PRJNA510744 | ENA

Genomic instability in the naturally and prematurely aged myocardium [variants: data set 2]

Project description:Genomic instability in the naturally and prematurely aged myocardium [variants: data set 2]

| PRJNA530713 | ENA

Genomic instability in the naturally and prematurely aged myocardium [variants: data set 1]

Project description:Genomic instability in the naturally and prematurely aged myocardium [variants: data set 1]

| PRJNA510748 | ENA

Genomic instability in the naturally and prematurely aged myocardium [RNA-Seq]

Project description:Our data demonstrate that genomic instability does not evidently contribute to naturally aging of the mouse heart and support the contention that the endogenous DNA repair machinery is remarkably active to maintain genomic integrity in cardiac cells throughout life.

2021-09-15 | GSE124005 | GEO

Genomic instability in the naturally and prematurely aged myocardium [variants: data set 2]

2021-09-15 | GSE129278 | GEO

Genomic instability in the naturally and prematurely aged myocardium [variants: data set 1]

2021-09-15 | GSE124083 | GEO

Genomic instability in the naturally and prematurely aged myocardium

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-09-15 | GSE124087 | GEO

Theophylline derivatives promote the activation of primordial follicles and ameliorate fertility deficits in naturally aged mice

Project description:The residual dormant primordial follicles in aged women and patients with premature ovarian insufficiency (POI) are difficult to activate in vivo. In this study, we found that PDE1A, PDE2A and PDE6D were expressed mainly in mouse primordial follicle oocytes and that PDE1A and PDE2A levels were significantly decreased during the activation of primordial follicles. The specific inhibitors of PDE1 (nimodipine), PDE2 (EHNA) and PDE5/6 (zaprinast) and the nonspecific PDE inhibitors theophylline derivatives (including aminophylline, dyphylline, enprofylline, choline theophyllinate, doxofylline, arofylline and lisofylline) activated mouse primordial follicles. These inhibitors also increased the levels of cyclic adenosine monophosphate (cAMP) and phosphorylated protein kinase B (p-Akt) in cultured mouse ovaries. Moreover, the administration of aminophylline, dyphylline and enprofylline to neonatal mice by intraperitoneal injection and to adolescent mice by oral treatment increased the number of growing follicle and the levels of p-Akt in the ovaries. Importantly, the oral administration of aminophylline increased the quantity and quality of ovulated oocytes and the number of offspring in naturally aged mice. In addition, aminophylline, dyphylline and enprofylline activated human primordial follicles and increased p-Akt levels. Thus, theophylline derivatives activate primordial follicles by increasing cAMP levels and activating the PI3K/Akt pathway, and the oral administration of aminophylline increases fertility in naturally aged female mice. As oral medications, theophylline derivatives may be used to increase fertility in aged women and patients with POI.

2024-05-30 | GSE263843 | GEO

Naturally-aged microglia exhibit phagocytic dysfunction accompanied by gene expression changes reflective of underlying neurologic disease

Project description:Age-associated microglial dysfunction contributes to the accumulation of amyloid-b (Ab) plaques in Alzheimer’s disease. Although several studies have shown age-related declines in the phagocytic capacity of myeloid cells, relatively few have examined phagocytosis of normally aged microglia. Furthermore, much of the existing data on aging microglial function have been generated in accelerated genetic models of Alzheimer’s disease. Here we found that naturally aged microglia phagocytosed less Ab over time. To gain a better understanding of such dysfunction, we assessed differences in gene expression between young and old microglia that either did or did not phagocytose Ab. Young microglia had both phagocytic and neuronal maintenance signatures indicative of normal microglial responses, whereas, old microglia, regardless of phagocytic status, exhibit signs of broad dysfunction reflective of underlying neurologic disease states. We also found downregulation of many phagocytic receptors on old microglia, including TREM2, an Ab phagocytic receptor. TREM2 protein expression was diminished in old microglia and loss of TREM2+ microglia was correlated with impaired Ab uptake, suggesting a mechanism for phagocytic dysfunction in old microglia. Combined, our work reveals that normally aged microglia have broad changes in gene expression, including defects in Ab phagocytosis that likely underlies the progression to neurologic disease.

2022-06-10 | GSE205803 | GEO

Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming

Project description:Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming

| PRJNA658337 | ENA